Metabolic Diseases Clinical Trial
— PFROfficial title:
Metabolic and Physiological Effects of Processing on Food Reward Encoding
NCT number | NCT06017986 |
Other study ID # | 21-1052 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | July 1, 2023 |
Est. completion date | July 1, 2026 |
The minimally processed diets of our ancestors have been rapidly replaced by UPFs driving poor diet to become the leading risk factor for preventable death globally. Hence, it is essential to understand what properties of UPF are driving their overconsumption to reduce diet-related mortality. To address this gap in knowledge this proposal will test: - If UPFs have a greater post meal metabolic response when compared to MPFs an essential signal for food reward - Through the use of an auction task paradigm if UPFs overvalued and if this value is differentially encoded in the brain This study is a fully cross-over design in that each participant receives all conditions and therefore serves as their own control. All orders of foods will be counterbalanced. Although participants cannot be blinded to the conditions as they must be aware of the foods they are eating, they will not be made aware that the key manipulation is food processing. On different days participants will come to the lab and consume a meal containing either minimally or ultra-processed foods as determined by the widely used NOVA (not an acronym) scale. These conditions will be consumed in a whole room metabolic chamber allowing for simultaneous measurement of multiple metabolic responses (glucose, insulin, and metabolic rate). These measures will be collected for 45 min before consumption of the meal (baseline) and for 3 hours after consumption (post-prandial). All participants will also undergo a Becker-Degroot-Marschak auction paradigm that consists of foods that are either minimally or Ultra-processed in the MRI scanner. Food value will be measure in participants' willingness to pay for each food and Neural responses will be measured during presentation of the food cues.
Status | Recruiting |
Enrollment | 74 |
Est. completion date | July 1, 2026 |
Est. primary completion date | July 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - BMI between 18.5-24.9 kg/m2 - Not pregnant or planning to become pregnant during study participation Residing in the Roanoke area and/or willing/able to attend sessions at the Fralin Biomedical Research Institute - Able to speak and write in English - Participants must be able to see a computer display clearly with or without vision correction (eyeglasses, contacts). Exclusion Criteria: - Claustrophobia (this would make lying in an MRI scanner or indirect calorimetry canopy very uncomfortable). 2. History of head injury resulting in loss of consciousness for more than 10 minutes 3. Current or past diagnosis of diabetes or metabolic disorder (thyroid disease, etc.) 4. Contraindications to MRI: Individuals with pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel worker, or other implants. 5. History of alcohol or drug dependence 6. Active neurologic disorder 8. Diagnosed eating disorder 9. Food allergies or restrictive diet |
Country | Name | City | State |
---|---|---|---|
United States | Fralin Biomedical Research Institute at VTC | Roanoke | Virginia |
Lead Sponsor | Collaborator |
---|---|
Virginia Polytechnic Institute and State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood glucose response to level of food processing | Blood glucose concentration will be assessed at baseline and at set time points for 3 hours after consumption of each condition on different days. | Immediately post intervention | |
Primary | Blood insulin response to level of food processing | Blood insulin concentration will be assessed at baseline and at set time points for 3 hours after consumption of each condition on different days. | Immediately post intervention | |
Primary | Energy expenditure in response to level of food processing | Whole room indirect calorimetry will be used to determine energy expenditure at baseline (for 45 minutes) and for 3 hours after consumption of each condition on different days. | Immediately post intervention | |
Primary | Respiratory exchange ratio in response to level of food processing | Whole room indirect calorimetry will be used to determine respiratory exchange ratio at baseline (for 45 minutes) and for 3 hours after consumption of each condition on different days. | Immediately post intervention | |
Primary | Substrate oxidation in response to level of food processing | Whole room indirect calorimetry will be used to determine substrate oxidation at baseline (for 45 minutes) and for 3 hours after consumption of each condition on different days. | Immediately post intervention | |
Primary | Effect of food processing on food value and encoding | A food picture set of 28 that are matched on 23 visual, perceptual, and nutritional properties but vary on degree of NOVA food processing level will be used in a Becker-Degroot-Marschak auction paradigm to assess participants' brain reward response for each food. | through study completion, an average of 3 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02380846 -
The Metabolic Effects of Consuming Carbohydrate With Different Protein Types
|
N/A | |
Not yet recruiting |
NCT01916603 -
Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development
|
N/A | |
Completed |
NCT02402985 -
Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics
|
N/A | |
Completed |
NCT01616082 -
Effect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)
|
N/A | |
Completed |
NCT01737164 -
Effect of Age on Glucose and Lipid Metabolism
|
N/A | |
Terminated |
NCT00935766 -
Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
|
Phase 3 | |
Enrolling by invitation |
NCT00628199 -
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
|
||
Recruiting |
NCT04958109 -
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
|
Phase 1 | |
Completed |
NCT02275429 -
Metabolic Disorders in Ultramarathon Runners During and After the Reunion Island Madmen's Diagonal
|
N/A | |
Completed |
NCT01968720 -
Pilot Study To Assess CAT-2003 in Patients With Severe Hypertriglyceridemia
|
Phase 2 | |
Completed |
NCT01719913 -
The Effect of Gluten on Gut Microbiome and Metabolic Health.
|
N/A | |
Completed |
NCT01708681 -
Lean Seafood Intake and Postprandial Metabolism
|
N/A | |
Completed |
NCT01705782 -
The Effects of Amino Acid Supplement During Acute Inflammation.
|
N/A | |
Completed |
NCT01435382 -
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
|
Phase 1 | |
Recruiting |
NCT02629926 -
Transitional Growth Hormone (GH) Use in Growth Hormone Deficient (GHD) Cancer Survivors
|
Phase 4 | |
Completed |
NCT00707746 -
Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects
|
Phase 2 | |
Completed |
NCT00550706 -
Drug Utilization Prevalence in a Pediatric Care Medical Center
|
N/A | |
Completed |
NCT03941392 -
Nutritional Study in Spanish Pediatric Population
|
||
Terminated |
NCT02440945 -
Use of the DBS for the Follow-up of Blood Clinical Parameters of Old People
|
N/A | |
Not yet recruiting |
NCT06000605 -
Brain Substrate Switch to Ketones and Lactate
|
N/A |